Apple Intelligence could get a shot in the arm from app developers with iOS 19 — here's how
iOS developers could soon start building AI features directly into their apps using Apple's own AI models.
According to a recent Bloomberg report, Apple plans to introduce a new software development kit (SDK) in iOS 19 that will make it easier for app developers to add AI features, and potentially create their own.
This SDK will feature the same large language models that Apple is currently using for Apple Intelligence features like Writing Tools, Genmoji, and Image Playground. However, the SDK will initially be focused on smaller models that run on-device, meaning developers likely won't be able to delegate tasks to external servers.
This release is likely due to many of Apple's features not yet seeing widespread adoption compared to the likes of Google Gemini.
Currently, developers can add certain Apple Intelligence features to apps but they can't create new ones without the help of third-party models. Apple's new SDK could mitigate this, giving users more opportunities to get on the Apple Intelligence bandwagon.
There's little doubt that Apple's AI rollout has had a lot of issues, especially when it comes to getting features to users.
The first hurdle was that any user with a phone older than the iPhone 15 Pro and onwards wasn't able to make use of Apple Intelligence in the first place. If that wasn't bad enough, many of the improved Siri features revealed for iOS 18 during WWDC 2024 were delayed until iOS 19 because they didn't work as intended.
Get instant access to breaking news, the hottest reviews, great deals and helpful tips.
Apple has also been asked to comply with an EU ruling that will allow European users to select a different default AI on their devices in the EU countries.
The release of this SDK seems like a decent initial solution from Apple when it comes to getting its AI features in front of customers. We expect to hear more on this (as well as the future of Apple Intelligence in general) at WWDC 2025, which kicks off next month on Monday, June 9.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
23 minutes ago
- Business Insider
Stock Market News Review: SPY, QQQ Dip as U.S.-China Tensions Flare, Consumer Sentiment Ends Losing Streak
Both the S&P 500 (SPX) and the Nasdaq 100 (NDX) closed the Friday session well above their afternoon lows, although the benchmark indices were unable to finish in the green ahead of the weekend. Confident Investing Starts Here: This morning, President Trump accused China of violating the preliminary trade deal reached by the countries in Geneva. He didn't dive into the specifics, though he later said in an Oval Office press conference that he would like to speak with China President Xi Jinping about the situation. 'Hopefully we'll work that out,' said Trump. U.S. Trade Representative Jamieson Greer provided more details, saying that China was moving too slowly in removing tariff countermeasures and that it hadn't progressed in removing export restrictions on rare earth metals used in products like vehicles and semiconductors. The market sunk lower during the afternoon after Bloomberg reported that the U.S. is preparing sanctions on subsidiaries of Chinese technology companies included in the Entity List. Sources close to the matter added that the U.S. will likely enforce additional restrictions following the subsidiary sanctions in a sign of escalation between the two world powers. Aside from trade updates, the University of Michigan's May Index of Consumer Sentiment tallied in at 52.2, beating the expectation for 51.0 and ending four consecutive months of falling sentiment. The reading remained unchanged from April and was much higher than the preliminary May reading of 50.8 as a result of the U.S.-China preliminary trade agreement. On top of that, the core personal consumption expenditures (PCE) index for April tallied in at 2.5%, meeting expectations and falling from 2.7% in March. The index is the Fed's preferred inflation gauge and excludes food and energy prices included in the PCE index because of their volatility. The S&P 500 ended the day just barely lower with a 0.01% loss while the Nasdaq 100 fell by 0.11%. At the same time, May turned out to be quite a memorable month, as both indexes registered their strongest monthly performance since November 2023.
Yahoo
an hour ago
- Yahoo
Hims & Hers Health trims workforce amid strategic realignment
-- Hims Hers Health Inc (NYSE:HIMS), a telehealth firm known for offering consumer-focused digital healthcare, is reducing its headcount by more than 4% as part of a pivot in its business strategy, according to Bloomberg. The decision impacts 68 employees across multiple divisions of the San Francisco-based company, which employs over 1,600 staff. The layoffs come as Hims moves away from leveraging regulatory loopholes that allowed it to sell cheaper, compounded versions of in-demand weight-loss drugs like Wegovy and Zepbound. With brand-name shortages largely resolved, the firm is shifting its attention to longer-term strategic investments. 'While not easy, this step reflects our commitment to invest in the areas that will define our future,' a spokesperson for the company said in a statement provided to Bloomberg. 'As part of this broader change, we will continue to actively hire for roles critical to our long-term strategy.' The news was first disclosed in Emily Sundberg's business newsletter Feed Me, following months of speculation about how telehealth platforms would adapt as the market for weight-loss drugs stabilizes. Hims had quickly become a key player by offering lower-cost alternatives when supply constraints propelled demand for off-brand equivalents. The company's valuation has soared, with its market capitalization reaching $12.7 billion as of its latest earnings report. This rapid growth was largely fueled by sales of compound versions of high-profile medications, capitalizing on temporary shortages that opened a window for telehealth platforms to scale. To sustain momentum, Hims recently announced a deal with Novo Nordisk A/S (NYSE:NVO) to distribute branded Wegovy at discounted rates. That partnership marks a notable departure from the firm's earlier reliance on generics and compounded imitators, indicating a move toward legitimizing its pharmaceutical offerings through strategic alliances. Industry watchers suggest the strategy may help the firm navigate rising scrutiny from U.S. regulators over compounded drugs and online prescribing practices. While details about which roles will be eliminated were not disclosed, the company affirmed its intention to continue hiring in key growth areas, as it seeks to revolutionize the telehealth industry. Hims stock rose 7.9% in trade Friday. Related articles Hims & Hers Health trims workforce amid strategic realignment TSX falls marginally on U.S.-China talks stalling, despite GDP growth California senate probing Paramount over 2024 $15M offer to Trump's campaign
Yahoo
an hour ago
- Yahoo
Why Wall Street downgrades of Apple stock are about to pile up
Shares of Apple AAPL — already down 20% since the beginning of the year — are likely to fall even further in coming months. That prediction is based on the behavior of Wall Street analysts, who tend to react slowly to developments. Seven of the almost 50 analysts who regularly follow Apple's stock have downgraded it this year. That leaves a large group of analysts who potentially could join this group of seven, and whose downgrades could cause Apple's stock to fall even further. 'You never know what might happen': How do I make sure my son-in-law doesn't get his hands on my daughter's inheritance? Five emerging pillars of stock-market support that should keep investors from rushing the exits My ex-wife said she should have been compensated for working part time during our marriage. Do I owe her? My daughter's boyfriend, a guest in my home, offered to powerwash part of my house — then demanded money S&P 500 scores best May since 1990, but stocks end month with fresh tariff worries Analysts' sluggishness in responding to new information is tied to their career and compensation incentives. It's risky for them to deviate too far from the Wall Street consensus. If they're wrong, their reputation will suffer and they possibly could lose their job. As such, they are inclined to keep their earnings estimates and buy-hold-sell ratings in the middle of the pack. This herd instinct was famously described by the late British economist John Maynard Keynes as 'worldly wisdom teaches that it is better for reputation to fail conventionally than to succeed unconventionally.' This theory of analyst behavior leads to a number of empirical predictions that have been borne out by research. One, as confirmed by this study, is that a downgrade of a given stock is more likely to be followed by another downgrade rather than an upgrade — and vice versa. This phenomenon is illustrated by the chart above, which plots the number of downgrades and upgrades of Apple stock over the trailing six months. Notice the preponderance of downgrades (the red columns) over the past few months. Another consequence of analyst sluggishness is that the stock market reacts more quickly than analysts to developments that affect a company's prospects. One study, for example, found that the analyst consensus on a given stock reflects just two-thirds of the information that the market itself has already taken into account. You might conclude from this result that equity analyst upgrades and downgrades should simply be ignored, since there would be no role for them to play if the stock market has already discounted all relevant new information. But the stock market isn't that perfect. Researchers have found that as analysts finally take into account the information the market has already incorporated, prices move even more. This is why it's a good bet there will be more downgrades of Apple stock in the coming months — and why shareholders will suffer even more than they have already. Mark Hulbert is a regular contributor to MarketWatch. His Hulbert Ratings tracks investment newsletters that pay a flat fee to be audited. He can be reached at More: Apple has been the worst Big Tech stock lately. Here's why investors are missing the big picture. Also read: Here's why Nvidia's stock is climbing despite a disappointing forecast It's my dream to travel to Africa. My husband says it's not on his bucket list. Do I pay for him or go alone? My friend is getting divorced. Her husband kindly said, 'Take the house.' Is there a catch? My husband used my money to renovate his house. Will I now get half of his property in a divorce? 'Is this a good tax strategy or a sham transaction?' My mother wants to give me her home. I have a plan to avoid taxes. Nvidia results are proof the tech sector is worth investor loyalty, says strategist who recommended buying at April lows Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
